chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 10 min after receiving 2nd dose of vaccine, c/o nausea and feeling dizzy--as if room spinning.  Stated she had this after 1st dose as well little different this time (first dose given at different location) VS --P-96, R-20. unable to obtain b/p as she was shaking--awake and alert . Started to feel somewhat better few minutes later--EMS notified,.  Upon arrival of EMS attempted b/p again w/o success.
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Joint Pain-Medium, Additional Details: Reports low grade fever (temp>99.8) & chills on Day 12 after 1st dose, lasting 3 days. Reports swelling/inflammation on Day 14, lasting til 10/1. Started with right knee, then right foot (big toe & ankle), then left wrist and ring finger. Pt alternated APAP 500mg BID and Motrin 800mg TID to help with pain/body aches/swelling. Pt does not take any maintenance medication, has history of gout (1-2 flares per year, not treated with meds).
Redness size of palm observed around injection site day after receiving vaccine, subjective temperature the evening of vaccine injection.
No second dose after 6 weeks; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (No second dose after 6 weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (No second dose after 6 weeks). At the time of the report, PRODUCT DOSE OMISSION ISSUE (No second dose after 6 weeks) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing was delayed on an unknown date.       No concomitant product was provided by the reporter.  No treatment medication was provided.   Reporter did not allow further contact
irritability,rash starting on extremities&ended up covering body&face;started about 48hrs p/vax;pt given Depomedrol on 1MAY96 @ MD office,& DPH PRN
Patient  came in for 2nd dose and was already anxious about getting the vaccine as he had the same fainting episode after the first dose. Rph and intern giving vaccine where both in the immunization room along with the dad.  Rph counseled patient on what to do if feeling light headed and to help prevent fainting . Intern gave vaccine and within a few seconds he said it was getting dark and so immediately as the patient was sitting down I grabbed him gently from the front and his dad came and held him from behind. We both supported him as he was sitting down and within 10 seconds he came back and was fine.  We then moved him to the floor lifted his legs and supported his head and he remained there for about  20 minutes. He then sat up slowly and we monitored him sitting for another10 minutes. He we doing well. My intern then proceeded to help his dad walk them out to the car. The dad did NOT want us to call paramedics as this was a known issues with his son fainting after getting immunizations. Made a follow up phone call with patient after about an hour and half and dad said he was doing great.
Runny nose; Sneezing; Feeling cold; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RHINORRHOEA (Runny nose), SNEEZING (Sneezing), FEELING COLD (Feeling cold) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Diabetes.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HEADACHE (Headache). On 04-Mar-2021, the patient experienced RHINORRHOEA (Runny nose), SNEEZING (Sneezing) and FEELING COLD (Feeling cold). At the time of the report, RHINORRHOEA (Runny nose), SNEEZING (Sneezing), FEELING COLD (Feeling cold) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications reported were Diabetic medication, Blood Pressure medications, Blood thinners ( drugs not specified- unknown indication). No treatment information was provided.
This case was reported by a consumer via out of hour services and described the occurrence of fever in a female patient who received Influenza vaccine Quadrivalent unspecified season. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced fever, generalized rash and scales. The patient was treated with Steroids. On an unknown date, the outcome of the fever, generalized rash and scales were recovered/resolved. It was unknown if the reporter considered the fever, generalized rash and scales to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. On an unknown date, the patient had flu shot of Influenza vaccine Quadrivalent unspecified season. The patient developed a fever and proceeded then to rash and scale from the top of her head to toes and she was in that condition for a week and had to receive steroids, high dose steroids to get through it.
Arm pain, swelling in face and neck, difficulty swallowing hives, tachycardia 160's,  o2 saturation in low 90's, shortness of breath, chest pain, diarrhea, nausea, vomiting, intractable headache in first 24 hrs, went to the ER around 9 pm October 1st, treated with solumedrol, Zofran, famatodine, saline bolus. Home prescription for pepcid and prednisone.  October 2nd signs and symptoms, hives on stomach, stiff neck, chest pain, headache.
Ache joints, acid reflux, cramps legs, lacrimation disorder (tears probably sicca), increase in forgetfulness, runny nose, tachycardia, weight gain.
Information has received from a physician concerning a patient who on an unspecified date, was vaccinated with a dose of ZOSTAVAX (Merck) for the prevention of shingles.  The physician reported that on an unknown date, the patient experienced "flu-like symptoms" after receiving the zoster vaccine.  The patient sought unspecified medical attention.  Outcome was not reported.   Additional information has been requested.
Vaccines given 12 noon 1/12/12. Mother called 3 pm 1/13/12. States the right leg is red, swollen, has a hive on right cheek and can a temp of 106 in the night - given TYLENOL and sponge bath - better but about 2:30 pm 1/13 - temp going back up - 101 - referred to doctor or ER - ASAP.
Chills, muscle aches, fatigue, headache, redness and soreness at injection site- this occurred beginning 3 days later)
Within 4 hours of receiving the injection I was unable to move my right shoulder.  There  was excrutiating pain.  Upon removing my bandaid it was apparent that the vaccine was injected just below my acromion.  I have a picture of the injection site.  My shoulder continued to ache (there was no aching in the muscles of my arm). I took Advil 600-80 mg tid and Tramadol 50 mg at night.  The pain woke me from sleep.  It was difficult to get dressed and undressed.  After 9 days of pain I finally took Prednisone 30 mg po.  This improved y pain by 30%.  It became clear that this is likely bursitis.
Moderna Covid-19 Vaccine EUA Vaccine found to be out of date after dose administered on 8/4/21.
Getting covid after vaccination series; perfusion sweating; didn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting covid after vaccination series), HYPERHIDROSIS (perfusion sweating) and MALAISE (didn't feel good) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting covid after vaccination series) (seriousness criterion hospitalization), HYPERHIDROSIS (perfusion sweating) (seriousness criterion hospitalization) and MALAISE (didn't feel good) (seriousness criterion hospitalization). At the time of the report, COVID-19 (Getting covid after vaccination series), HYPERHIDROSIS (perfusion sweating) and MALAISE (didn't feel good) outcome was unknown.            No concomitant drug details were reported. No treatment details were reported.  The patient was later discharged 4-58 hours later.  Company comment: Very limited information regarding this events has been provided at this time. This report refers to a case of Drug ineffective for mRNA-1273, lot numbers unspecified with AEs. There is no information on date of vaccine doses and start date of events, but case is processed assuming that the patient had 2 doses of Moderna vaccine in the correct interval (25-35 days). For the event COVID-19, based on the mechanism of action of mRNA-1273 causal association between the event of COVID-19 infection and mRNA-1273 is assessed as not applicable. For the rest of the events, based on the current available information and temporal association between the use of the product and the events, a causal relationship cannot be excluded.; Sender's Comments: Very limited information regarding this events has been provided at this time. This report refers to a case of Drug ineffective for mRNA-1273, lot numbers unspecified with AEs. There is no information on date of vaccine doses and start date of events, but case is processed assuming that the patient had 2 doses of Moderna vaccine in the correct interval (25-35 days). For the event COVID-19, based on the mechanism of action of mRNA-1273 causal association between the event of COVID-19 infection and mRNA-1273 is assessed as not applicable. For the rest of the events, based on the current available information and temporal association between the use of the product and the events, a causal relationship cannot be excluded.
Patient reports soreness at vaccine administration site.  Intermittent waves of pain  starting around 11/4-11/5.  Rated 3-9 on pain scale, described as severe ache.   On 11/6, pain was rated as a nine.   Patient denies taking any medication or other methods (i.e. ice, massage) to reduce pain.
Pfizer Booster given to a 15 year old. Currently not approved for this age.
The child stopped all cognitive and language development and lost his ability to say "mama" & "dada", to attend to teaching and he quit laughing and socially interacting. Diagnosed with Autism.  Also diagnosed with gastroenteritis. *F/UP report on 3/31/03: PT continues to be severely autistic w/no consistent speech. He had recent lab results which shows 2x's level of exposure to mercury that he is now expelling due to chelation therapy.*
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Fever, body aches and chills lasting 24 hours. Temp of 99-101.
7AUG92 lump lt arm 1 1/2 x 1 1/2 warm to touch;
Client came to Covid vaccine clinic and attested on consent form that he has never received a Covid Vaccine before. Client provided a dose of Janssen on 9/30/21, and later it was determined that client had already received a dose of Janssen on 5/6/2021.
Two days after the second dose of the vaccine I had pain  pain in my lower right side. I was nauseous and in pain for two days. I went to the ER and they identified  I appendicitis and I had my Appendix removed four days after the vaccine. The procedure was performed outpatient. Two months after the vaccine I also had Diverticulitis.
DOS 12/20, 12/21. 3 day hx redness, itching and swelling at vaccine site. TX: Amoxicillin-clavulanate.
Cellulitis on left arm - pt started getting really sore and developed a large welt (as big as man's hand). Pt went to urgent care and was told to watch. It has decreased in size and patient says it is getting better.
She developed a runny nose around January 24, 2023. She also developed a cough around January 27, 2023. She ran 100.5-degree fever January 27 and 28, 2023. She was still coughing and had a runny nose on January 31, 2023. I took her to see the doctor. They tested her for RSV and the Flu. She tested positive for RSV. The doctor did not prescribe medication but told us to continue the humidifier and ibuprofen as needed. She also suggested wearing a mask around older family members. She began feeling better around February 4, 2023. Her symptoms almost completely resolved by February 9, 2023. She continues to have a slight cough first thing in the morning. She has a follow-up appointment to address that issue today.
swelling, warmth, redness in upper arm after receiving immunizations on 4/14, same day started doctor exam - diffuse redness of the left upper arm with fullness, induration, and increased warmth from office visit 4/16, treated for cellulitis with cephalexin oral  -per note from doctor, on 4/18, swelling & redness fully resolved
Patient got a higher dose than the recommended because of the mistake while mixing the diluent to the vaccine; Patient is really nervous about it; Patient got a higher dose than the recommended because of the mistake while mixing the diluent to the vaccine; Patient is really nervous about it; Patient is really nervous about it; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19-19 mRNA VACCINE, Solution for injection, Lot number: FC3181, Expiration date was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, caller stated, caller had question about the Covid Vaccination that's why was calling and not sure if you can answer it but really need answer for a patient (consumer), the patient got a higher dose than the recommended because of the mistake while mixing the diluent to the vaccine. The patient had been contacted and everything, but the patient wanted to know what she should do. What is the consequence if the higher than the recommended dose was given by mistake, so she trying to find an answer for her because she was really nervous about. She had called earlier they said that had to call back Monday but the patient said that it is an Emergency situation and needed answer and should had a way to find somebody who can answer that question to her. When paraphrased the concern, reporter stated, Yes if there is any evidence on like what happens if it is ok or should she be worried about or shouldn't worry things like that. As reporter was not willing to proceed the call. Caller stated, somebody had already taken her information his name was withheld, so don't think, I really have to go to help the customers. The outcome of the events was unknown.
Information has been received from a female patient of unknown age concerning herself. The patient had no concomitant medication or drug reactions/allergies. Medical history was not reported. On 20-FEB-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route, lot# and expiration date were unknown) for prevention of infection from pneumococcus bacteria. The injection site did turn red after being vaccination on the same day. On next day 21-FEB-2017, the patient had chills, no appetite and a bad taste in her mouth. After returning home from work, she tried to regurgitate but could not. The patient then took EX-LAX (OLD FORMULA) to clean herself out and felt much better afterwards. The patient did contact her physician. There was no treatment given for the events. The outcome of the events was reported as recovered (unknown date in February 2017). No product quality complaint involved. Additional information has been requested.
liver bleed; pneumonia; kidney failure; Sepsis; lungs filled up with fluid; heart issues; were told they would need to wait 90 days as they were to far out of the date range; were told they would need to wait 90 days as they were to far out of the date range; This is a spontaneous report from a Pfizer-sponsored program, COVAX US Support. A contactable consumer (patient's spouse) reported that a male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose on 29Jan2021 and could not receive the second vaccine due to being hospitalized on an unspecified date due to gall bladder removal, sepsis, kidney failure, heart issues, lungs filled up with fluid, pneumonia, and liver bleed. The patient went to the facility to receive second vaccine and were told they would need to wait 90 days as they were to far out of the date range and was refused. The doctor refuses to administer the vaccine (other company) as they have started with the Pfizer vaccine. The outcome of the events was unknown.  Information about batch/lot number has been requested.
Pt started with red streaking in her arm 1 day after getting the vaccine. He had the vaccine before and never had a reaction. Pt was treated with KEFLEX.
Red rash with warmth to injection site of right upper arm. Fever, fatigue. Stuffy nose, chills.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. Vaccine was given 6 days post expiry date.   This case was linked to MOD-2021-395985 (Patient Link).
Information was received 13-OCT-2016 via telephone call from a registered nurse who reported that an improperly stored dose of Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate) was administered to an 8 month old patient on 10-OCT-2016. The reported lot numbers are: # M014925, expiration date 16-FEB-2019 and Lot # M010439, expiration date 08-DEC-2018. It was not specified which lot # was administered to this patient. No adverse effects reported. This report was due to data logger. This is one of several reports from the same source. Additional information was requested.
Narrative:  Patient received four doses of COVID vaccine Jan x2 2021/Sep 2021/Apr 2022. The patient tested positive for COVID 19 on 20 Sep 2022. The patient presented to the ED on 20 Sep 2022 with shortness of breath, wheezing, and cough. The patient was admitted to the hospital with COVID 19 and bronchitis. The patient was treated with antibiotics, oxygen, inhalers, and steroids. The patient was discharged in stable condition on 23 Sep 2022. Reported per EUA.
Arm sensitivity; Tiredness; false positive (benign) swollen right lymph node/Swollen lymph node opposite side of vaccine/Lymph nodes that could be a concern; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of LIMB DISCOMFORT (Arm sensitivity), LYMPHADENOPATHY (false positive (benign) swollen right lymph node/Swollen lymph node opposite side of vaccine/Lymph nodes that could be a concern) and FATIGUE (Tiredness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 032M20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL and ATORVASTATIN for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 09-Feb-2021, the patient experienced LYMPHADENOPATHY (false positive (benign) swollen right lymph node/Swollen lymph node opposite side of vaccine/Lymph nodes that could be a concern). On an unknown date, the patient experienced LIMB DISCOMFORT (Arm sensitivity) and FATIGUE (Tiredness). At the time of the report, LIMB DISCOMFORT (Arm sensitivity), LYMPHADENOPATHY (false positive (benign) swollen right lymph node/Swollen lymph node opposite side of vaccine/Lymph nodes that could be a concern) and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Mammogram: (Positive) false positive (benign) swollen right lymph node. In 2021, Diagnostic procedure: Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Mar-2021: Suspect product batch/lot number were updated. Lab data and event were added. On 09-Jul-2021: Patient demographics were updated.
Patient came to pharmacy on 7/11/20, reporting severe side effects from Shingrix. Her left shoulder was significantly swollen, she reported it was hot, and her arm motion was severely limited due to pain and swelling. Symptoms started day of vaccination (7/10/20). Patient was willing to try treating from home by icing swollen/hot/painful areas and using acetaminophen. Patient was instructed to go to urgent care/ER if she was no longer comfortable trying to treat from home or if her symptoms got progressively worse. I spoke with patient this morning (7/12/20) and she reported gaining some limited motion back in her arm, but it was still swollen, hot, and painful. She reported icing five times throughout the previous day and using acetaminophen 650mg every 8 hours. Patient's MD was notified today. Patient plans on contacting MD 7/13/20 and asking for appointment to be seen. Pharmacy will also follow up with patient.